Ipamorelin
Selective ghrelin mimetic with minimal impact on cortisol or prolactin.

Research overview
Ipamorelin is a synthetic pentapeptide and a selective agonist of the Growth Hormone Secretagogue Receptor (GHSR-1a), the same receptor activated by the endogenous hormone ghrelin. It belongs to the Growth Hormone-Releasing Peptide (GHRP) class of growth hormone secretagogues.
Its mechanism of action involves binding to GHSR-1a in the anterior pituitary gland and hypothalamus, triggering a pulsatile release of the body's own growth hormone (GH). Ipamorelin is distinguished within its class by its high degree of selectivity: unlike earlier GHRPs such as GHRP-2 and Hexarelin, it stimulates GH release with minimal impact on other hormones, producing little to no elevation in cortisol, prolactin, or aldosterone, and without significantly increasing appetite.
This clean pharmacological profile has made Ipamorelin a widely studied experimental peptide. It is often investigated in combination with a Growth Hormone-Releasing Hormone (GHRH) analogue such as CJC-1295, where the two compounds act on complementary pathways to produce a synergistic increase in GH and Insulin-like Growth Factor 1 (IGF-1) levels.
Peer-Reviewed Research (PubMed)
Selected landmark / highly-cited studies indexed on PubMed.
- 1.Ipamorelin, the first selective growth hormone secretagogueRaun K, et al. — European Journal of Endocrinology, 1998
- 2.Ghrelin and its potential in the treatment of growth hormone/insulin-like growth factor 1 axis disordersGarin MC, et al. — JCEM, 2013
- 3.Growth hormone secretagogues: a long way from medicinal chemistry to clinical implicationsSigalos JT, Pastuszak AW. — Sexual Medicine Reviews, 2018
Studied benefits
- Stimulates pulsatile GH release
- Supports lean mass preservation
- Improves recovery and sleep
- Minimal side-effect profile in studies
Trusted U.S. research-peptide suppliers
We source and benchmark against established U.S.-based research-peptide manufacturers and distributors. Each supplier below operates under cGMP-aligned synthesis with documented CoA, HPLC, and mass-spec validation for research use only.
Logos are property of their respective owners and shown for reference only. Listing does not imply endorsement or an exclusive supply relationship.
Inquire about Ipamorelin
Share your research context so our team can recommend the right purity grade, documentation, and quantity. A scientific contact responds personally.
Related peptides
Long-acting GHRH analog with Drug Affinity Complex, designed to sustain elevated GH and IGF-1 levels.
Short-acting GHRH analog (Mod GRF 1-29) studied for pulsatile GH release with rapid clearance.
Growth Hormone Releasing Peptide-2 studied for potent, pulsatile GH release.

